Judith van Asperen
- Oncology top 2%
- Pediatrics, Perinatology and Child Health top 1%
- Pharmacology top 1%
- Molecular Biology
- Pharmaceutical Science top 2%
- Co-authors
- Jos H. BeijnenOlaf van TellingenAlfred H. SchinkelPiet BorstUlrich MayerAlex SparreboomWillem J. NooijenJohan W. Smit
- Topics
- Drug Transport and Resistance Mechanisms (10 papers)Pharmacological Effects and Toxicity Studies (6 papers)Effects and risks of endocrine disrupting chemicals (2 papers)
- Journals
- Proceedings of the National Academy of SciencesJNCI Journal of the National Cancer InstituteNeuroscience & Biobehavioral Reviews
- Partner nations
- NetherlandsUnited KingdomBelgium
In The Last Decade
Judith van Asperen
20 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 1.3k
- Pediatrics, Perinatology and Child Health 686
- Pharmacology 403
- Molecular Biology 383
- Pharmaceutical Science 200
Countries citing papers authored by Judith van Asperen
This map shows the geographic impact of Judith van Asperen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith van Asperen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith van Asperen more than expected).
Fields of papers citing papers by Judith van Asperen
This network shows the impact of papers produced by Judith van Asperen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith van Asperen. The network helps show where Judith van Asperen may publish in the future.
Co-authorship network of co-authors of Judith van Asperen
This figure shows the co-authorship network connecting the top 25 collaborators of Judith van Asperen. A scholar is included among the top collaborators of Judith van Asperen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith van Asperen. Judith van Asperen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 44 | |
| 2 | 5 | |
| 3 | 42 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 14 | |
| 10 | 74 | |
| 11 | 13 | |
| 12 | 124 | |
| 13 | 6 | |
| 14 | 101 | |
| 15 | Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A. | 122 |
| 16 | 92 | |
| 17 | 109 | |
| 18 | Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestinebreakdown → | 749 |
| 19 | 173 | |
| 20 | 148 |
About Judith van Asperen
Judith van Asperen is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Oncology (1.3k citations), Pharmacology (403 citations) and Pediatrics, Perinatology and Child Health (686 citations). Judith van Asperen has collaborated with scholars based in Netherlands, United Kingdom and Belgium. Frequent co-authors include Jos H. Beijnen, Olaf van Tellingen, Alfred H. Schinkel, Piet Borst, Ulrich Mayer, Alex Sparreboom, Willem J. Nooijen, Johan W. Smit, Dirk K. F. Meijer and W J Nooijen. Their work appears in journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Neuroscience & Biobehavioral Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.